Universe Pharmaceuticals Stock Performance
| UPC Stock | USD 3.65 0.09 2.41% |
On a scale of 0 to 100, Universe Pharmaceuticals holds a performance score of 4. The entity has a beta of 1.75, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Universe Pharmaceuticals will likely underperform. Please check Universe Pharmaceuticals' sortino ratio, skewness, price action indicator, as well as the relationship between the potential upside and rate of daily change , to make a quick decision on whether Universe Pharmaceuticals' existing price patterns will revert.
Risk-Adjusted Performance
Soft
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Universe Pharmaceuticals are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Universe Pharmaceuticals exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (2.41) | Five Day Return (4.20) | Year To Date Return (85.82) | Ten Year Return (99.98) | All Time Return (99.98) |
Last Split Factor 1:40 | Last Split Date 2025-03-24 |
1 | How high can Universe Pharmaceuticals INC stock go - Layoff News Community Consensus Stock Picks - newser.com | 09/30/2025 |
2 | Universe Pharmaceuticals INC Sees Significant Growth in Short Interest | 10/09/2025 |
3 | Facteus Generates 76 percent Alpha with Exclusive Card UPC Transaction Data Portfolio on 1 Day Lag | 10/16/2025 |
4 | Visualizing Universe Pharmaceuticals INC stock with heatmaps - 2025 Market Sentiment Expert Verified Movement Alerts - newser.com | 10/20/2025 |
5 | Visualizing Universe Pharmaceuticals INC stock with heatmaps - Gap Up Community Consensus Trade Alerts - newser.com | 10/28/2025 |
6 | Discretionary transaction by Moore Jackson W of tradable shares of Universe Pharmaceuticals subject to Rule 16b-3 | 11/03/2025 |
7 | How supply chain issues affect Universe Pharmaceuticals INC stock - Quarterly Market Summary Real-Time Buy Zone Alerts - fcp.pa.gov.br | 11/04/2025 |
8 | Universe Pharmaceuticals Trading Down 2.4 percent Whats Next | 11/12/2025 |
| Begin Period Cash Flow | 5.3 M | |
| Total Cashflows From Investing Activities | -361.3 K |
Universe Pharmaceuticals Relative Risk vs. Return Landscape
If you would invest 342.00 in Universe Pharmaceuticals on August 19, 2025 and sell it today you would earn a total of 23.00 from holding Universe Pharmaceuticals or generate 6.73% return on investment over 90 days. Universe Pharmaceuticals is generating 0.6243% of daily returns assuming volatility of 11.8875% on return distribution over 90 days investment horizon. In other words, majority of equities are less volatile than Universe, and most equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Universe Pharmaceuticals Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Universe Pharmaceuticals' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Universe Pharmaceuticals, and traders can use it to determine the average amount a Universe Pharmaceuticals' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0525
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | UPC | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 11.89 actual daily | 96 96% of assets are less volatile |
Expected Return
| 0.62 actual daily | 12 88% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 4 96% of assets perform better |
Based on monthly moving average Universe Pharmaceuticals is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Universe Pharmaceuticals by adding it to a well-diversified portfolio.
Universe Pharmaceuticals Fundamentals Growth
Universe Stock prices reflect investors' perceptions of the future prospects and financial health of Universe Pharmaceuticals, and Universe Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Universe Stock performance.
| Return On Equity | -0.23 | ||||
| Return On Asset | -0.0827 | ||||
| Profit Margin | (0.50) % | ||||
| Operating Margin | (0.25) % | ||||
| Current Valuation | (37.49 M) | ||||
| Shares Outstanding | 563.34 K | ||||
| Price To Earning | 3.02 X | ||||
| Price To Book | 0.04 X | ||||
| Price To Sales | 0.11 X | ||||
| Revenue | 23.02 M | ||||
| Gross Profit | 5.87 M | ||||
| EBITDA | (7.36 M) | ||||
| Net Income | (8.73 M) | ||||
| Cash And Equivalents | 28.58 M | ||||
| Cash Per Share | 1.31 X | ||||
| Total Debt | 7.99 M | ||||
| Debt To Equity | 0.07 % | ||||
| Current Ratio | 5.06 X | ||||
| Book Value Per Share | 97.96 X | ||||
| Cash Flow From Operations | (9.51 M) | ||||
| Earnings Per Share | (255.68) X | ||||
| Market Capitalization | 2.11 M | ||||
| Total Asset | 67.95 M | ||||
| Retained Earnings | (10.17 M) | ||||
| Working Capital | 31.32 M | ||||
About Universe Pharmaceuticals Performance
By analyzing Universe Pharmaceuticals' fundamental ratios, stakeholders can gain valuable insights into Universe Pharmaceuticals' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Universe Pharmaceuticals has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Universe Pharmaceuticals has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 43.01 | 72.75 | |
| Return On Tangible Assets | (0.15) | (0.14) | |
| Return On Capital Employed | (0.19) | (0.18) | |
| Return On Assets | (0.15) | (0.14) | |
| Return On Equity | (0.22) | (0.21) |
Things to note about Universe Pharmaceuticals performance evaluation
Checking the ongoing alerts about Universe Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Universe Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Universe Pharmaceuticals is way too risky over 90 days horizon | |
| Universe Pharmaceuticals appears to be risky and price may revert if volatility continues | |
| Universe Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the last year's revenue of 23.02 M. Reported Net Loss for the year was (8.73 M) with profit before taxes, overhead, and interest of 5.87 M. | |
| Universe Pharmaceuticals has about 28.58 M in cash with (9.51 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.31. | |
| Latest headline from thelincolnianonline.com: Universe Pharmaceuticals Trading Down 2.4 percent Whats Next |
- Analyzing Universe Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Universe Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
- Examining Universe Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Universe Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Universe Pharmaceuticals' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Universe Pharmaceuticals' stock. These opinions can provide insight into Universe Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Universe Stock analysis
When running Universe Pharmaceuticals' price analysis, check to measure Universe Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Universe Pharmaceuticals is operating at the current time. Most of Universe Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Universe Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Universe Pharmaceuticals' price. Additionally, you may evaluate how the addition of Universe Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Global Correlations Find global opportunities by holding instruments from different markets |